Does TECLISTAMAB-CQYV Cause White blood cell count increased? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of White blood cell count increased have been filed in association with TECLISTAMAB-CQYV. This represents 0.9% of all adverse event reports for TECLISTAMAB-CQYV.
14
Reports of White blood cell count increased with TECLISTAMAB-CQYV
0.9%
of all TECLISTAMAB-CQYV reports
0
Deaths
0
Hospitalizations
How Dangerous Is White blood cell count increased From TECLISTAMAB-CQYV?
Of the 14 reports.
Is White blood cell count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause White blood cell count increased?
CLOZAPINE (2,988)
ADALIMUMAB (1,710)
RUXOLITINIB (1,529)
IBRUTINIB (1,390)
RITUXIMAB (886)
METHOTREXATE (741)
PREDNISONE (716)
ETANERCEPT (615)
IMATINIB (520)
TOCILIZUMAB (478)
Which TECLISTAMAB-CQYV Alternatives Have Lower White blood cell count increased Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL